Gene signatures associated with GBM stem cells and pericytes were highly expressed in hypermetabolic lesions, which are characterized by elevated DPEP1 mRNA expression, as compared to hypometabolic lesions. The gene discussed is DPEP1; the disease is glioblastoma.